In particular, LPA derived from ovarian cancer cells was recently shown to promote a glycolytic shift in ovarian cancer cells [118] and in normal fibroblasts through HIF-1a, thus leading to the transformation of fibroblasts into cancer-associated-fibroblasts (CAFs) [119]. Here, HIF1A is linked to ovarian carcinoma.